House of Lords Business
Show full summary

Baroness Prosser to ask Her Majesty's Government, further to the answer by Lord O'Shaughnessy on 7 June (HL Deb, col 1405), what assessment they have made of the credibility of the National Institute for Health and Care Excellence (NICE) process to approve drugs for use by NHS England; and what discussions they have held with NHS England on the subject of the application of NICE standards for Ibrutinib.  HL10002

Question HL10002: tabled on 4 September 2018 and due for answer by 18 September 2018

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Baroness Prosser to ask Her Majesty's Government, further to the answer by Lord O'Shaughnessy on 7 June (HL Deb, col 1405), what assessment they have made of the credibility of the National Institute for Health and Care Excellence (NICE) process to approve drugs for use by NHS England; and what discussions they have held with NHS England on the subject of the application of NICE standards for Ibrutinib.  HL10002
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Baroness Prosser
Labour
Life peer